Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2009 Mar;123(3):687-8.
doi: 10.1016/j.jaci.2009.02.003.

Assessing anaphylactic risk? Consider mast cell clonality

Editorial

Assessing anaphylactic risk? Consider mast cell clonality

Dean D Metcalfe et al. J Allergy Clin Immunol. 2009 Mar.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Bonadonna P, Perbellini O, Passalacqua G, Caruso B, Colarossi S, Dal Fiore D, et al. Clonal mast cells disorders in patients with systemic reactions to hymenoptera sting and raised serum tryptase. J Allergy Clin Immunol. In press. - PubMed
    1. Akin C, Scott LM, Kocabas CN, Kushnir-Sukhov N, Brittain E, Noel P, et al. Demonstration of an aberrant mast-cell population with clonal markers in a subset of patients with “idiopathic” anaphylaxis. Blood. 2007;110(7):2331–3. - PMC - PubMed
    1. Schwartz LB, Bradford TR, Rouse C, Irani A-M, Rasp G, Van der Zwan JK, et al. Development of a new, more sensitive immunoassay for human tryptase: Use in systemic anaphylaxis. J Clin Immunol. 1994;14:190–204. - PubMed
    1. Ludolph-Hauser D, Rueff F, Fries C, Schopf P, Przybilla B. Constitutively raised serum concentrations of mast-cell tryptase and severe anaphylactic reactions to Hymenoptera stings. Lancet. 2001;357(9253):361–2. - PubMed
    1. Simons FE, Frew AJ, Ansotegui IJ, Bochner BS, Golden DB, Finkelman FD, et al. Risk assessment in anaphylaxis: current and future approaches. J Allergy Clin Immunol. 2007;120(1 Suppl):S2–24. - PubMed